Real-world clinical outcomes of patients with BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: a CancerLinQ® study

Purpose To investigate real-world clinical outcomes in patients with BRCA-mutated (BRCAm), HER2-negative metastatic breast cancer (mBC) according to BRCA and hormone receptor (HR) status. Methods Patients diagnosed with HER2-negative mBC between 01 January 2010 and 31 December 2018 were retrospectiv...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast cancer research and treatment 2022-05, Vol.193 (1), p.83-94
Hauptverfasser:	Miller, Robert S., Mokiou, Stella, Taylor, Aliki, Sun, Ping, Baria, Katherine
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - therapy Cancer Cancer research Care and treatment Clinical outcomes Clinical Trial Computational linguistics Diagnosis Epidermal growth factor ErbB-2 protein Female Humans Language processing Medicine Medicine & Public Health Metastases Metastasis Natural language interfaces Oncology Oncology, Experimental Patient outcomes Patients Receptor, ErbB-2 - genetics Receptor, ErbB-2 - metabolism Retrospective Studies Triple Negative Breast Neoplasms - drug therapy Triple Negative Breast Neoplasms - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!